Menu
01. Mesothelioma Care

Mesothelioma Care at Vanderbilt-Ingram Cancer Center

The Vanderbilt-Ingram Cancer Center is at the forefront of lung cancer and mesothelioma treatment, providing screenings, second opinions and individualized treatment for a patient’s cancer.

Specialists at the Vanderbilt-Ingram Cancer Center have experience diagnosing the disease, as well as providing second opinions, with a variety of tests like CT scans, MRIs and endoscopic ultrasounds. The center provides a variety of treatment options depending on the patient’s individual case, including advanced robotic surgery, minimally invasive surgery, immunotherapy, radiation and chemotherapy. Radiation is used as a treatment or as a palliative therapy to reduce symptoms and manage pain. The center offers targeted therapy, biologic therapy and clinical trials to patients as alternative treatment options, as well. They assess the cancer on an individual basis, using genetic testing to find the best treatment options.

Patient navigators are also available to patients to relieve them of the stress of scheduling appointments and collecting medical and financial records. Patients may access survivorship and support services as part of their care at the Vanderbilt-Ingram Cancer Center.

02. Specializations

Vanderbilt-Ingram Cancer Center Specializations

  • Chemotherapy
  • Radiation therapy
  • Surgery
  • Targeted therapy
03. Accreditations

Vanderbilt-Ingram Cancer Center Accreditations

  • CEO Cancer Gold Standard
  • National Cancer Institute (NCI) Comprehensive Care Center
  • National Cancer Institute (NCI) National Clinical Trials Network accreditation
  • National Comprehensive Cancer Network (NCCN) accreditation
04. Mesothelioma Clinical Trials

Mesothelioma Clinical Trials at Vanderbilt-Ingram Cancer Center

The following clinical trials are in progress or actively recruiting participants at Vanderbilt-Ingram Cancer Center:

Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin


Conditions: Neoplasms, Mesothelioma, Lung Neoplasms

Last Updated: June 10, 2019

Status: Recruiting

Locations: Duarte, CA. Los Angeles, CA. Los Angeles, CA. Pasadena, CA. Sacramento, CA. Aurora, CO. Baltimore, MD. Ann Arbor, MI. Rochester, MN. Columbus, OH. Pittsburgh, PA. Nashville, TN. Nashville, TN. Madison, WI.

Collecting Tumor Samples From Patients With Gynecological Tumors


Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Rhabdomyosarcoma, Germinoma, Leiomyosarcoma, Vulvar Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Cystadenocarcinoma, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Cystadenocarcinoma, Serous, Carcinoma, Adenosquamous, Brenner Tumor, Sarcoma, Endometrial Stromal, Rhabdomyosarcoma, Embryonal

Last Updated: October 26, 2016

Status: Completed

Locations: Fayetteville, AR. Fayetteville, AR. Little Rock, AR. Burbank, CA. Long Beach, CA. Los Angeles, CA. Orange, CA. Palo Alto, CA. Sacramento, CA. San Francisco, CA. Sylmar, CA. Aurora, CO. Aurora, CO. Danbury, CT. Hartford, CT. New Britain, CT. New Haven, CT. Fort Lauderdale, FL. Fort Myers, FL. Jupiter, FL. Miami, FL. Atlanta, GA. Augusta, GA. Gainesville, GA. Savannah, GA. Chicago, IL. Chicago, IL. Chicago, IL. Oak Lawn, IL. Springfield, IL. Indianapolis, IN. Indianapolis, IN. South Bend, IN. Clive, IA. Clive, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Iowa City, IA. West Des Moines, IA. West Des Moines, IA. Ashland, KY. Edgewood, KY. Lexington, KY. Louisville, KY. Baton Rouge, LA. New Orleans, LA. Shreveport, LA. Portland, ME. Baltimore, MD. Baltimore, MD. Bethesda, MD. Springfield, MA. Worcester, MA. Worcester, MA. Ann Arbor, MI. Detroit, MI. Flint, MI. Grand Rapids, MI. Minneapolis, MN. Jackson, MS. Jackson, MS. Kessler AFB, MS. Columbia, MO. Saint Louis, MO. Saint Louis, MO. Springfield, MO. Springfield, MO. Springfield, MO. Omaha, NE. Las Vegas, NV. Las Vegas, NV. Lebanon, NH. Camden, NJ. Hackensack, NJ. Hackensack, NJ. Newark, NJ. Albuquerque, NM. Buffalo, NY. Mineola, NY. New York, NY. New York, NY. Stony Brook, NY. Chapel Hill, NC. Charlotte, NC. Charlotte, NC. Greenville, NC. Greenville, NC. Greenville, NC. Pinehurst, NC. Winston-Salem, NC. Akron, OH. Cincinnati, OH. Cincinnati, OH. Cleveland, OH. Columbus, OH. Columbus, OH. Mentor, OH. Oklahoma City, OK. Tulsa, OK. Tulsa, OK. Portland, OR. Portland, OR. Abington, PA. Allentown, PA. Bethlehem, PA. Danville, PA. Philadelphia, PA. Philadelphia, PA. Pittsburgh, PA. Pittsburgh, PA. State College, PA. Wilkes-Barre, PA. Providence, RI. Charleston, SC. Greenville, SC. Spartanburg, SC. Rapid City, SD. Sioux Falls, SD. Sioux Falls, SD. Sioux Falls, SD. Chattanooga, TN. Johnson City, TN. Knoxville, TN. Memphis, TN. Nashville, TN. Nashville, TN. Amarillo, TX. Austin, TX. Dallas, TX. Dallas, TX. Dallas, TX. Dallas, TX. Fort Sam Houston, TX. Galveston, TX. Houston, TX. Lackland AFB, TX. Lubbock, TX. Lubbock, TX. Temple, TX. Hampton, VA. Roanoke, VA. Auburn, WA. Centralia, WA. Federal Way, WA. Lakewood, WA. Olympia, WA. Olympia, WA. Puyallup, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Chippewa Falls, WI. Eau Claire, WI. Eau Claire, WI. Ladysmith, WI. Madison, WI. Marshfield, WI. Marshfield, WI. Milwaukee, WI. Milwaukee, WI. Milwaukee, WI. Minocqua, WI. Rhinelander, WI. Rice Lake, WI. Stevens Point, WI. Stevens Point, WI. Wausau, WI. West Allis, WI. Weston, WI. Weston, WI. Wisconsin Rapids, WI.

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies


Conditions: Carcinoma, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms, Carcinoma, Squamous Cell, Carcinoma, Hepatocellular, Lymphoma, B-Cell, Uterine Cervical Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Small Cell Lung Carcinoma, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Mesothelioma, Triple Negative Breast Neoplasms, Carcinoma, Transitional Cell, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Merkel Cell, Microsatellite Instability

Last Updated: April 10, 2019

Status: Recruiting

Locations: Los Angeles, CA. Hackensack, NJ. Huntersville, NC. Nashville, TN.

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors


Conditions: Colorectal Neoplasms, Head and Neck Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Mesothelioma, Neoplasm Metastasis

Last Updated: November 29, 2018

Status: Recruiting

Locations: Mobile, AL. Scottsdale, AZ. Tucson, AZ. Baltimore, MD. Boston, MA. Boston, MA. Detroit, MI. Nashville, TN. Nashville, TN. Houston, TX. Houston, TX. San Antonio, TX.

Photo of Vanderbilt-Ingram Cancer Center

Get Help Contacting Vanderbilt-Ingram Cancer Center

Where Should We Overnight Your Free Guide?



    Privacy policy: All information is secure and will never be released

    TRUSTe